Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data DIEBOLD NIXDORF, Inc files with the SEC in its annual reports.
In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.
Income statement
FY2015
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2024
FY2025
Revenue
2,419
3,316
4,609
4,579
4,409
3,902
3,905
3,461
3,751
3,806
Cost of revenue
1,767
2,605
3,610
3,680
3,342
2,867
2,862
2,703
2,831
2,845
Gross profit
652
712
1,000
899
1,067
1,035
1,043
757
920
961
Research and development
86.9
110
156
157
147
133
126
121
93.6
86.7
Selling, general and administrative
488
761
934
894
909
859
776
742
644
633
Operating expenses
593
882
1,093
1,224
-1,094
-1,011
906
969
738
719
Operating income
58.6
-170
-93.5
-326
-26.6
24
137
-212
182
242
Interest expense
32.5
101
117
155
203
267
195
199
155
85.7
Other non-operating income
-12.8
-78.9
-98.4
-153
-202
-294
-188
-227
-135
-117
Pre-tax income
45.8
-249
-192
-478
-229
-270
-50.7
-439
47.3
125
Income tax
-13.7
-69
28.3
37.2
117
-1
27.7
149
64.3
24.1
Income from continuing operations
57.8
-185
-242
-569
Net income to minority interests
1.7
6
27.6
2.7
-3.3
1.3
0.7
-4.2
2
2.9
Net income
73.7
-41.6
-242
-531
-341
-269
-78.8
-581
-16.5
94.6
EBITDA
123
-35
159
-77.8
200
97.7
208
-155
314
370
EPS, basic
1.41
-0.60
-3.20
-7.48
-4.45
-3.47
-1.01
-7.36
-0.44
2.57
EPS, diluted
1.40
-0.60
-3.20
-7.48
-4.45
-3.47
-1.01
-7.36
-0.44
2.54
Shares, basic (weighted)
51.9
69.1
75.5
76
76.7
77.6
78.3
79
37.6
36.8
Shares, diluted (weighted)
52.5
69.1
75.5
76
76.7
77.6
78.3
79
37.6
37.2
Dividend per share
1.44
0.96
0.40
0.10
0.00
0.00
Balance sheet
FY2015
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2024
FY2025
Cash and equivalents
314
653
535
458
281
325
389
307
296
369
Short-term investments
37.2
34.3
24.6
16.9
29.1
Receivables
414
836
828
737
619
647
595
612
589
609
Inventory
369
738
715
610
467
498
544
588
528
521
Other current assets
148
183
248
225
231
227
203
169
177
130
Total current assets
1,644
2,620
2,480
2,201
1,892
1,857
1,887
1,771
1,668
1,787
Property, plant and equipment
175
387
365
304
232
178
138
121
128
Lease right-of-use assets
0
168
143
152
109
118
141
Goodwill
162
998
1,046
798
764
800
744
702
586
642
Intangible assets
67.5
773
774
625
502
449
348
258
779
792
Long-term investments
85.2
94.7
96.8
22.4
21.4
10.3
11
7.6
7
Other non-current assets
7.5
63.1
95.8
86.4
91.1
123
132
97.4
195
242
Total assets
2,242
5,270
5,222
4,281
3,791
3,657
3,507
3,065
3,544
3,854
Accounts payable
282
561
562
510
472
500
706
612
460
431
Accrued liabilities
76.5
173
199
184
225
227
187
108
173
202
Deferred revenue
229
404
437
378
321
347
322
453
321
326
Short-term debt
0.2
Total current liabilities
956
1,825
1,796
1,568
1,600
1,650
1,749
1,605
1,266
1,372
Long-term debt
606
1,691
1,787
2,190
2,109
2,336
2,246
2,586
927
939
Lease liabilities
0
106
93.1
103
76.7
76.3
91.9
Other non-current liabilities
28.7
87.7
111
87.3
89.1
59.5
36.5
31.5
111
119
Total liabilities
1,814
4,262
4,740
4,403
4,297
4,489
4,344
4,436
2,605
2,750
Total debt
606
1,691
1,787
2,190
2,109
2,336
2,246
2,558
927
939
Paid-in capital
431
720
722
742
774
788
820
832
1,048
1,061
Retained earnings
760
663
375
-131
-472
-742
-822
-1,407
-1.1
91.9
Treasury stock
-560
-562
-567
-570
-572
-577
-582
-586
0
-131
Other comprehensive income
-318
-341
-196
-304
-375
-413
-379
-360
-118
77.8
Shareholders' equity
412
589
446
-150
-530
-827
-845
-1,381
930
1,100
Minority interests
23.1
433
36.8
26.8
24
-4.6
8.1
9.8
8.4
4.9
Total equity
428
1,009
482
-123
-506
-832
-837
-1,371
938
1,105
Total liabilities and equity
2,242
5,270
5,222
4,281
3,791
3,657
3,507
3,065
3,544
3,854
Shares outstanding
52
75.1
75.6
76.2
76.8
77.7
78.4
79.1
37.6
35.4
Cash flow statement
FY2015
FY2016
FY2017
FY2018
FY2019
FY2020
FY2021
FY2022
FY2024
FY2025
Net income
75.4
-35.6
-214
-529
-345
-268
-78.1
-586
-14.5
97.5
Depreciation and amortization
64
135
252
248
226
73.7
70.9
56.4
132
128
Stock-based compensation
12.4
22.2
33.9
36.6
24
14.9
13.8
13.4
9.7
12.1
Deferred income tax
-49.3
-43.8
-40.4
-14.5
78.4
-19.5
-12.8
93.4
-8.1
-48.1
Change in receivables
-56.4
102
23.9
51
112
-19.7
16.4
-49.4
99.6
25.9
Change in inventory
-51.2
137
21.8
-5.1
105
-14.8
-84.8
-74.5
20.9
65.1
Change in payables
57.6
-112
-6.3
-34.5
-33.1
10.6
241
-66.5
-42.2
-68.3
Cash from operations
37.2
28.7
37.1
-104
136
18
123
-388
149
301
Acquisitions
-59.4
-885
-5.6
-5.9
0
0
0
-24.5
Purchases of investments
-222
-241
-288
-401
-295
-318
Sales and maturities of investments
176
225
296
318
242
215
288
414
289
306
Cash from investing
-64.9
-561
-121
34.4
-6.8
-82.6
-49.2
-23.8
-45.5
-97.6
Debt issued
0
0
950
Debt repaid
0
0
-1,251
Stock issued
3.5
0.3
0.3
0
0
0
0
Share buybacks
-3
-2.2
-5
-3
-1.9
-6.6
-7.7
-7.8
0
-131
Dividends paid
-75.6
-64.6
-30.6
-7.7
0
0
Cash from financing
41.7
881
-63.7
10.9
-216
16.9
-3.6
350
-367
-144
Exchange rate effect
-23.9
-8
37.9
-18.7
-1.1
-3.2
-5.7
-8.2
-18.2
16.8
Net change in cash
-9.9
341
-110
-77.5
-87.6
-50.9
64.8
-70.1
-281
76
Interest paid
32.6
85.4
99.9
130
190
138
175
232
149
59.1
Income taxes paid
64.8
83.8
78.2
64.9
41.8
43.8
42.3
33.1
56.1
57.2
Key metrics
Worked out from the statements above. Latest values use the trailing twelve months to June 30, 2026; growth uses fiscal years. Valuation uses the share price of $62.72 on September 25, 2026.
Profitability
Metric
Value
How it is calculated
Gross margin
25.2%
Gross profit / revenue.
Operating margin
6.4%
Operating income / revenue.
EBITDA margin
8.3%
EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin
4.2%
Pre-tax income / revenue.
Net margin
2.9%
Net income / revenue.
Operating cash flow margin
7.1%
Cash from operations / revenue.
Effective tax rate
28.3%
Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)
11.5%
Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)
3.0%
Net income / average total assets.
Return on invested capital (ROIC)
10.8%
Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
R&D / revenue
2.2%
Research and development expense / revenue.
SG&A / revenue
16.7%
Selling, general and administrative expense / revenue.
Stock-based pay / revenue
0.3%
Stock-based compensation (from the cash flow statement) / revenue.
D&A / revenue
2.0%
Depreciation and amortization / revenue.
Growth
Metric
Value
How it is calculated
Revenue growth, 1y
1.5%
Revenue vs the same period a year earlier. Only from a positive base.
Gross profit growth, 1y
4.5%
Gross profit vs the same period a year earlier. Only from a positive base.
Operating income growth, 1y
32.9%
Operating income vs the same period a year earlier. Only from a positive base.
EBITDA growth, 1y
17.5%
EBITDA vs the same period a year earlier. Only from a positive base.
Operating cash flow growth, 1y
101.5%
Operating cash flow vs the same period a year earlier. Only from a positive base.
Book value growth, 1y
18.3%
Book value vs the same period a year earlier. Only from a positive base.
Total assets growth, 1y
8.8%
Total assets vs the same period a year earlier. Only from a positive base.
Share count change, 1y
-1.1%
Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Balance sheet health
Metric
Value
How it is calculated
Current ratio
1.27x
Current assets / current liabilities.
Quick ratio
0.63x
(Cash + short-term investments + receivables) / current liabilities.
Cash ratio
0.21x
(Cash + short-term investments) / current liabilities.
Debt / equity
0.97x
Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets
25.2%
Total debt / total assets.
Liabilities / assets
73.9%
Total liabilities / total assets.
Net debt
$660.5M
Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA
2.05x
Net debt / EBITDA (twelve months), when EBITDA is positive.
Days inventory + days sales outstanding - days payables.
Per share
Metric
Value
How it is calculated
EPS, diluted
$3.15
Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share
$109.69
Revenue / diluted weighted shares.
Operating cash flow per share
$7.73
Cash from operations / diluted weighted shares.
Book value per share
$28.50
Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Market cap + total debt - cash - short-term investments.
P/E
19.1x
Market cap / net income. Only when net income is positive.
P/S
0.55x
Market cap / revenue.
P/B
2.20x
Market cap / shareholders' equity. Only when equity is positive.
P/OCF
7.80x
Market cap / cash from operations, when positive.
EV/Sales
0.72x
Enterprise value / revenue.
EV/EBIT
11.3x
Enterprise value / operating income, when both are positive.
EV/EBITDA
8.64x
Enterprise value / EBITDA, when both are positive.
Earnings yield
5.2%
Net income / market cap (the inverse of P/E).
Shareholder yield
10.0%
(Dividends paid + share buybacks) / market cap.
What was DIEBOLD NIXDORF, Inc's revenue in fiscal 2025?
DIEBOLD NIXDORF, Inc reported revenue of $3.81B for fiscal 2025, 1.5% higher than the year before.
Was DIEBOLD NIXDORF, Inc profitable in fiscal 2025?
Yes. Net income was $94.6M, a net margin of 2.5%.
Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.